Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.
Loading...
Issue Date
7/13/2020
Authors
Rybak, Michael J
Le, Jennifer
Lodise, Thomas P
Levine, Donald P
Bradley, John S
Liu, Catherine
Mueller, Bruce A
Pai, Manjunath P
Wong-Beringer, Annie
Rotschafer, John C
Degree
Advisor
Committee Members
Journal Title
Journal ISSN
Volume Title
Abstract
Citation
Rybak MJ, Le J, Lodise T, Levine D, Bradley J, Liu C, Mueller B, Pai M, Wong-Beringer A, Rotschafer JC, Rodvold K, Maples HD, Lomaestro BM. Executive Summary: Therapeutic Monitoring of Vancomycin for Serious Methicillin-Resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):281-284. doi: 10.1093/jpids/piaa057. PMID: 32659787; PMCID: PMC7358040.